{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:28:55Z","timestamp":1738214935008,"version":"3.34.0"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T00:00:00Z","timestamp":1205971200000},"content-version":"vor","delay-in-days":5771,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[1992,6]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> The calcium homeostasis in eight patients with postoperative hypoparathyroidism was examined before and after 2 weeks of administration of verapamil in an oral dose of 80 mg three times daily. Serum ionized calcium increased during verapamil treatment (from mean \u00b1 SD of 110 \u00b1 006 to 1.24 \u00b1 0.38 mmol 1<jats:sup>\u20101<\/jats:sup>; <jats:italic>P<\/jats:italic> &lt;0.05), as well as total serum calcium corrected for protein (from 2.11\u00b10.13 to 2.18 \u00b1 0.13 mmol l<jats:sup>\u20101<\/jats:sup>; <jats:italic>P<\/jats:italic> &lt; 0.05). During treatment with verapamil there was an increase in serum phosphate (from 1.08 \u00b10.15 to 1.19\u00b10.20 mmol l<jats:sup>\u20101<\/jats:sup><jats:italic>P<\/jats:italic>\u2264 0.05) and in the urinary excretion of phosphate (<jats:italic>P<\/jats:italic>\/creatinine ratio from 1.22\u00b10.69 to 1.83 \u00b1 0.97; <jats:italic>P<\/jats:italic>\u22640.05). The serum 1,25\u2010dihydroxyvitamin\u2010Dj and serum parathyroid hormone were below the detection limits both before and after verapamil treatment. There were no significant changes either of the intestinal absorption of calcium or of the urinary calcium excretion. Serum osteocalcin was insignificantly reduced after treatment (1.60 \u00b1 0.70 before treatment and 1.25 \u00b1 0.71 \u03bcg l<jats:sup>\u20101<\/jats:sup> after treatment).<\/jats:p><jats:p>Thus in patients with post\u2010surgical hypoparathyroidism verapamil has effects on calcium and phosphorous homeostasis. Since calcium absorption was not influenced by verapamil, it is suggested that verapamil affects bone mineral metabolism.<\/jats:p>","DOI":"10.1111\/j.1365-2362.1992.tb01477.x","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T12:43:33Z","timestamp":1206017013000},"page":"378-382","source":"Crossref","is-referenced-by-count":3,"title":["Verapamil increases serum ionized calcium and serum phosphate in patients with post\u2010surgical hypoparathyroidism"],"prefix":"10.1111","volume":"22","author":[{"given":"G.","family":"SJ\u00d6D\u00c9N","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"ROSENQVIST","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"NORDENSTR\u00d6M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"BJ\u00d6RKHEM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A. V.","family":"ERIKSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"KRIEGHOLM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(77)90279-5"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000137890"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90347-X"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00582167"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03182.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00242.x"},{"key":"e_1_2_1_8_2","first-page":"83","article-title":"Effect of verapamil on plasma parathyroid hormone","volume":"25","author":"Bogin E.","year":"1987","journal-title":"J Clin Chem Clin Biochem"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(79)90046-7"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1978.tb08404.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/222797a0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-4-651"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/58.5.376"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(75)90307-1"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517409082499"},{"key":"e_1_2_1_16_2","first-page":"1729","article-title":"Effect of detergent on kinetic Jaff\u00e9method assay of creatinine","volume":"26","author":"Bergman A.","year":"1980","journal-title":"Clin Chim Acta"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/clinchem\/24.1.80","article-title":"New automated dye\u2010binding method for serum albumin determination with bromcresol purple","volume":"24","author":"Pinnell AE","year":"1978","journal-title":"Clin Chem"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517609055237"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(73)90430-0"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/29.6.1075"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-1-91"},{"key":"e_1_2_1_22_2","unstructured":"Siggard\u2010AndersenO. ThodeJ. WandrupJ.The concentration of free calcium ions in the blood plasma. Proceedings of the 5th meeting of the International Federation of Clinical Chemistry expert panel on pH and blood gases Copenhagen."},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/clinchem\/24.9.1545","article-title":"Measurement of free calcium in capillary blood and serum","volume":"24","author":"Fogh\u2010Andersen N.","year":"1978","journal-title":"Clin Chem"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.4.2234"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606652"},{"key":"e_1_2_1_26_2","first-page":"112","article-title":"Antihypertensive effect of verapamil in relation to plasma concentrations of verapamil and its active metabolite nor\u2010verapamil","volume":"29","author":"Storstein L.","year":"1981","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90219-1"},{"journal-title":"J Clin Endocrinol Metab","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","author":"Abugassa S.","key":"e_1_2_1_28_2"},{"key":"e_1_2_1_29_2","first-page":"93","article-title":"Treatment of asymptomatic hypothyroidism and hypocholesterolemia","volume":"121","author":"Hughes EA","year":"1989","journal-title":"J Endocrinol"},{"key":"e_1_2_1_30_2","unstructured":"SluiterHE HuysmansFTM ThienTA KoeneBAP.The effects of the dihydropyridine calcium antagonist felodipine on blood pressure and plasma ionized calcium levels in chronic treatment of refractory hypertension. (Abstract) Second International Meeting on Felodipine Frankfurt: poster 22."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.3109\/17453678509154160"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-108-6-2293"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-94-4-1022"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-105-5-1168"},{"key":"e_1_2_1_35_2","first-page":"267","article-title":"Osteocalcin\u2014biochemical considerations and clinical applications","volume":"226","author":"Lian JB","year":"1988","journal-title":"Clin Orthop"},{"key":"e_1_2_1_36_2","unstructured":"Official Statistics 1988 Apoteksbolaget AB (the National Corporation of Swedish Pharmacies) S\u2010105 14 Stockholm Sweden."}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.1992.tb01477.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.1992.tb01477.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:19:31Z","timestamp":1698081571000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.1992.tb01477.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["10.1111\/j.1365-2362.1992.tb01477.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.1992.tb01477.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"type":"print","value":"0014-2972"},{"type":"electronic","value":"1365-2362"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}